Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Evaluation of Bromocriptine, Metoprolol and Tamsulosin Combination Therapy in Eyes With Non-Central Diabetic Macular Edema

NCT03384524 is registered in ClinicalTrials.gov with Andrew Moshfeghi, MD, MBA as lead sponsor.

NCT NCT03384524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03384524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Evaluation of Bromocriptine, Metoprolol and Tamsulosin Combination Therapy in Eyes With Non-Central Diabetic Macular Edema
Lead sponsor
Andrew Moshfeghi, MD, MBA
Phase
Phase 1/2
Overall status
Withdrawn
Start date
March 31, 2018
Completion date
May 31, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema